Xiaojing Xu

1PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jan 07, 2023
Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer.

Xiaojing Xu, Mengling Liu, Ke Peng

Pageof 1

Frequent Collaborators

1 joint publications

Tianshu Liu